Abstract
The discovery of antibacterial agents, such as penicillin and streptomycin, led to the expectation that among the fermentation products of molds, substances with antiviral properties would be found. Many naturally occurring antiviral agents are able to inhibit virus replication in cultured cells in vitro (1), but unfortunately, almost all of them were found to be unsuitable for treatment of virus diseases. The alternative approach was to chemically synthesize antiviral compounds. Some of these were effective in inhibiting virus replication in mammalian cells, and a few are in use today for curing virus infections in man (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Becker, Y. Pharmac. Ther. 10: 119–159, 1980.
Becker, Y. and Hadar, J. Progr. Med. Virol. 26: 1–44, 1980.
Porter, A.G., Barber, C., Carey, N.J., Hallewell, R.A., Threlfall, G. and Emtage, J.S. Nature 282: 471–477, 1979.
Emtage, J.S., Tacon, W.C.A., Catlin, G.H., Jenkins, B., Porter, A.G. and Carey, N.H. Nature 283: 171–174.
Isaacs, A. and Lindenmann, J. Proc. Roy. Soc. Lond. (Biol.) 147: 258–267, 1957.
Gordon, J. and Minks, M.A. Microbiol. Rev. 45: 244–266, 1981.
Strander, H., Mogensen, K.E. and Cantell, K. J. Clin. Microb. 1: 116–117, 1975.
Mogensen, K.E. and Cantell, K. Pharmac. Therap. 1: 369–381, 1977.
Dunnick, J.K. and Galasso, G.J. J. Infect. Dis. 139: 109–123, 1979.
Krim, M. Blood 55: 875–884, 1980.
Derynck, R., Content, J., DeClercq, E., Volckaert, G., Tavernier, J., Devos, R. and Fiers, E. Nature 285: 536–542, 1980.
Nagata, S., Taira, H., Hall, A., Johnsrud, L., Streuli, M., Ecsddi, J., Boll, W., Cantell, K. and Weissman, C. Nature 284: 316–320, 1980.
Taniguchi, T., Mantei, N., Schwarzstein, M., Nagata, S., Muramatsu, M., and Weissman, C. Nature 285; 547–549, 1980.
Taniguchi, T., Guapente, L., Roberts, T.M., Kimelman, D., Douhan, D. Ill, and Ptashne, M. Proc. Natl. Acad. Sci. USA 77; 5230–5233, 1980.
Taniguchi, T., Pang, R.H.L., Yip, Y.K., Henriksen, D. and Vilcek, J. Proc. Natl. Acad. Sci. USA 78: 3469–3472, 1981.
Orchansky, P., Rubinstein, M. and Sela, I. Proc. Natl. Acad. Sci. USA 79: 2278–2280, 1982.
Devash, Y., Biggs, S. and Sela, I. Science 216: 1415–1416, 1982.
Shannon, W.M. and Schabel, F.M. Jr. Pharmac. Therap. 11: 263–390, 1980.
Manzari, F., Gallo, R.C., Franchini, G., Westin, E., Ceccherini-Nelli, L., Popovic, M. and Wong-Staal, F. Proc. Natl. Acad. Sci. USA 80: 11–15, 1983.
Sidwell, R.S., Robins, R.K. and Hillyard, I.W. Pharmac. Therap. 6: 123–146, 1979.
Fridlender, B., Chejanovsky, N., and Becker, Y. Virology 81: 551–554, 1978.
Fridlender, B., Chejanovsky, N., and Becker, Y. Antimicrob. Ag. Chemother. 13: 124–127, 1978.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Becker, Y. (1984). Introduction: Current Trends in the Research on Antiviral Drugs. In: Becker, Y., Hadar, J. (eds) Antiviral Drugs and Interferon: The Molecular Basis of Their Activity. Developments in Molecular Virology, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3804-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3804-8_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3806-2
Online ISBN: 978-1-4613-3804-8
eBook Packages: Springer Book Archive